Lumanta, Dexie Ann .
HRN: 23-73-93 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2023
AMPICILLIN 1GM (VIAL)
11/16/2023
11/16/2023
IV
2g
Q6
PROM
Waiting Final Action
11/16/2023
AMPICILLIN 1GM (VIAL)
11/16/2023
11/16/2023
IV
2g
Q6
PROM
Waiting Final Action
11/16/2023
AMPICILLIN 1GM (VIAL)
11/16/2023
11/16/2023
IV
2g
Q6
PROM
Waiting Final Action
11/16/2023
CEFUROXIME 500MG (TAB)
11/16/2023
11/22/2023
ORAL
500mg
BID
PROM, Rmle
Waiting Final Action